Comment from National Right to Life

Summary: The National Right to Life Committee (NRLC) opposes the GenBioPro petition, arguing that mifepristone carries significant medical risks and requires stricter safety protocols, such as the restoration of earlier REMS requirements. They contend that the drug can lead to serious complications, including surgical intervention and psychological distress, and urge the FDA to reject the petition and consider reversing the drug's approval.